|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Oocyte activation as a bioassay for functional viability of oocytes after vitrification显示文摘 | Villines P M Gentry W L Wegner C C | 2005 | Fertil Steril2005，84，1： | 1 |
| 2 | Predictors of Short- and Long-Term Outcomes of Takotsubo Cardiomyopathy显示文摘 | Mukesh Gopalakrishnan Abdalla Hassan Dana Villines Sharif Nasr Mercy Chandrasekaran Lloyd W. Klein | 2015 | The American Journal of Cardiology2015，，： | 1 |
| 3 | Predictorsof short- and long-term outcomes of takotsubo cardiomyopa-thy显示文摘 | Gopalakrishnan M Hassan A Villines D | 2015 | Am J Cardiol2015，116，10： | 1 |
| 4 | The relation- ship between subclinical atherosclerosis, non-high-density lip- oprotein cholesterol, exercise, and diet among male partici- pants of the PACC Project 显示文摘 | SIMPRINI L A VILLINES T C RICH M | 2012 | J Clin Lipidol2012，6，2： | 1 |
| 5 | Statin therapy for subclinieal atherosclerosis in pri- maryprevention:time to prove it 显示文摘 | Villines TC | 2012 | JACC Cardiovase Imaging2012，5，3： | 1 |
| 6 | Coblation tonsillectomy in children: Incidence of bleeding 显示文摘 | Walner DL Miller SP Villines D | 2012 | Laryngoscope2012，122，10： | 1 |
| 7 | The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis) 显示文摘 | VILLINES TC STANEK EJ DEVINE PJ | 2010 | J Am Coll Cardiol2010，55，24： | 1 |
| 8 | The ARBITER 6- HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis ): final results and the impact of medication adherence, dose, and treatment duration 显示文摘 | Villines TC Stanek EJ Devine PJ | 2010 | J Am Coil Cardiol2010，55，24： | 1 |
| 9 | The ARBITER 6-HALTS Trial (Arterial biology for the treatment effects of reducing cholesterol 6-HDL and LDL treatment strategies in atheroclerosis):final results and the impact of medication adherence,dose,and treatment duration显示文摘 | VILLINES T C STANEK E J DEVINE P J | 2010 | J Am Coll Cardiol2010，55，： | 1 |
| 10 | Paradoxical progression of atherosclerosis related to low-density lipoprotein reduction and exposure to ezetimibe 显示文摘 | Taylor A J Villines TC Stanek EJ | 2012 | Eur Heart J2012，33，23： | 1 |
| 11 | Live births after autologous transplant of cryopreserved mouse ovaries显示文摘 | Gunasena KT Villines PM Critser ES | 1997 | Hum Reprod1997，12，1： | 1 |
| 12 | Extended-rclease niacin or ezetimibe and carotid intima-media thickness显示文摘 | Taylor AJ Villines TC Stanek EJ | 2009 | N Engl J Med2009，361，22： | 1 |
| 13 | Extended-release niacin or ezetimibe and carotid intima-media thickness 显示文摘 | Taylor AJ Villines TC Stanek EJ | 2009 | N Engl J Med2009，361，22： | 1 |
| 14 | Percutaneous closure versus medical therapy alone for cryptogenic stroke pa- tients with a patent foramen ovale: meta-analysis of random- ized controlled trials显示文摘 | Pickett CA Villines TC Ferguson MA | 2014 | Tex Heart Inst J2014，41，4： | 1 |
| 15 | Niacin:the evidence,clinical use,and future directions显示文摘 | Villines TC Kim AS Gore RS | 2012 | Curr Atheroscler Rep2012，14，1： | 1 |
| 16 | Anxiety, depression, and pain: differences by primary cancer显示文摘 | Fischer D J Villines D Kim YO | 2010 | Support Care Cancer2010，18，7： | 1 |
| 17 | The ARBITER 6-HALTS trial ( arterial biology for the investigation of the treatment effects of reducing cholesterol 6-HDL and LDL treatment strategies in atherosclerosis ) : final results and the impact of medication adherence, dose, and treatment duration 显示文摘 | Villines TC Stanck EJ Devine PJ | 2010 | JAm Coil Cardiol2010，55，24： | 1 |
| 18 | Extended-release niacin or ezetimibe and carotid intima-media thickness显示文摘 | Taylor AJ Villines TC Stanek EJ | 2009 | N Engl J Med2009，361，22： | 1 |
| 19 | Live births after autologous transplant of cryopreserved mouse ovaries显示文摘 | Gunssens KT Villines PM Critser ES et aI | 1997 | Hum F:eprod1997，17，： | 1 |
| 20 | Extended-Release Niacin or Ezetimibe and Carotid Intima-Media Thickness 显示文摘 | Taylor AJ Villines TC Stanek EJ | 2009 | N Engl J Med2009，361，22： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员